Navigation Links
3 New Lung Cancer Genes Identified
Date:10/9/2007

They are associated with 20 percent of all lung malignancies, scientists say

TUESDAY, Oct. 9 (HealthDay News) -- Three genes that appear to work together are associated with 20 percent of lung cancers, and these same genes are linked to fetal lung development, researchers report.

Understanding how these genes mesh could be an important step in stopping tumors from forming, according to the report in this week's issue of the Proceedings of the National Academy of Sciences.

"We have discovered a frequent genetic mutation in lung cancer," said lead researcher David Mu, from the Cold Spring Harbor Laboratory in New York. "This mutation is found in 20 percent of non-small cell lung cancer, which makes up about 80 percent of all lung cancer."

For the study, Mu's team looked at lung cancer tumor tissue and found that the three genes -- designated TTF1, NKX2-8 and PAX9 -- work together to promote tumor growth. The genes are located next to each other on chromosome 14.

These genes are also involved in the normal development of lungs in the embryo, Mu said. "However, in adults, they can be mutated into a malignant form helping lung cells turn into cancer cells," he said.

This phenomenon of three genes working together to enable cancer cells appears to be unique to lung cancer, he said.

Mu noted that this finding could have important medical applications. "We are looking at identifying patients with this type of mutation to find out what prognosis they have," he said. "We are actively researching this."

It may also be possible to block these gene mutations and prevent tumor growth, Mu said. "Understanding how these genes work is important. In addition, there may be other genes that are important for the function of these genes and might be better targets for therapy," he said.

Dr. Michael Thun, head of epidemiological research at the American Cancer Society, said the discovery could lead one day to predicting lung cancer prognosis and designing individual treatment.

"There is a search on to find the gene mutations involved in cancer," he said. "If you know what genes are malfunctioning in a cancer, it is useful in predicting prognosis, and you can tailor treatment to fit the abnormalities that are present in the tumor tissue."

Thun also said that knowing the genetic components of a cancer can help determining who's at risk for developing a specific malignancy.

More information

For more on lung cancer, visit the U.S. National Cancer Institute.



SOURCES: David Mu, Ph.D., Cold Spring Harbor Laboratory, N.Y.; Michael Thun, M.D., head, epidemiological research, American Cancer Society, Atlanta; Oct. 8-12, 2007, Proceedings of the National Academy of Sciences


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Vitamin B12 can help in detecting cancers
6. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
7. Consensus on "Combination Therapy" for Breast Cancer
8. Cancers of Colon & Rectum linked to Cigarette Smoking
9. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
10. The Cancer Rumour mill working over time
11. Want skin cancer? Please have a cigarette
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: